![Cureus | Proton Pump Inhibitors: Exploring Cardiovascular Complications and Prescription Protocol | Article Cureus | Proton Pump Inhibitors: Exploring Cardiovascular Complications and Prescription Protocol | Article](https://assets.cureus.com/uploads/figure/file/240628/lightbox_eddc5180e7e811ebbe70b79f4b23b4ca-diagram.png)
Cureus | Proton Pump Inhibitors: Exploring Cardiovascular Complications and Prescription Protocol | Article
![Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis | Scientific Reports Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-39335-7/MediaObjects/41598_2019_39335_Fig1_HTML.png)
Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis | Scientific Reports
![Cureus | Co-prescription of Dual-Antiplatelet Therapy and Proton Pump Inhibitors: Current Guidelines | Article Cureus | Co-prescription of Dual-Antiplatelet Therapy and Proton Pump Inhibitors: Current Guidelines | Article](https://assets.cureus.com/uploads/figure/file/256612/lightbox_6c0c24e0842e11ec9d3543a14118533f-lightbox_a22099900a1111ec8605fbd3db5d9d31-Picture1.png)